| Literature DB >> 32233019 |
Ba Hoang Anh Mai1,2, Michel Drancourt1, Gérard Aboudharam1,3.
Abstract
INTRODUCTION: Dental pulp with special structure has become a good reference sample in paleomicrobiology-related blood-borne diseases, many pathogens were detected by different methods based on the diagnosis of nucleic acids and proteins.Entities:
Keywords: ancient dental pulp; infectious diseases; nucleic acids; paleomicrobiology; proteins
Mesh:
Substances:
Year: 2020 PMID: 32233019 PMCID: PMC7284042 DOI: 10.1002/mgg3.1202
Source DB: PubMed Journal: Mol Genet Genomic Med ISSN: 2324-9269 Impact factor: 2.183
Pulp volume of each teeth type from nine ancient male mandibles was measured by CT‐Scanner (unpublished data)
| Teeth type |
|
Pulp volume Mm3 |
|
|---|---|---|---|
| Incisors | 32 | 12.4 ± 3.3 | <.05 |
| Canines | 17 | 36.1 ± 10.2 | |
| Premolars | 35 | 24.1 ± 7.2 | |
| Molars | 35 | 56.7 ± 13.2 |
FIGURE 1Methods for pathogens detection in ancient dental pulp
FIGURE 2Schematic cross‐section of a premolar and a mandibular molar representing the different tissues. (1) Enamel, (2) Dentine, (3) Dental pulp, (4) Cementum, (5) Keratinized gum, (6) Blood vessel and nerves, terminale vascularization, (7) Periodontal ligament, (8) Alveolar bone, (9) Nerve and blood supply, (10) Periodontal pocket with dental calculus
Summary of comparative results
|
| ||||
|---|---|---|---|---|
|
Percentage of positive teeth: iPCR: 41.2% PCR: 29.4% ELISA: 8.8% Combination of 3 techniques: 53% (Malou et al., | Ancient dental pulp |
Quantity of DNA extraction (Schuenemann et al., < Amplification of DNA (Schuenemann et al., > | Ancient bone | RDT (+), PCR(−) (Haensch et al., |
|
RDT positive percentage (Bianucci et al., > | ||||
|
RDT positive percentage (Bianucci et al., < | ||||
Studies for pathogens detection in ancient dental pulp
| Microorganism | Locations | Datation | Methods | Target | Teeth percentage | Reference |
|---|---|---|---|---|---|---|
| Pathogens detection in ancient dental pulp of human | ||||||
|
| Marseille ‐ France | 1972 | Standard PCR | Sequencing rpoB (133‐bp) gene and pla (300‐bp) | 50% (4/8) | Drancourt et al. ( |
| Lambesc ‐ France | 1590 | 50% (2/4) | ||||
| Vienna ‐ Austria | 7−9th | Suicide nested PCR | Sequencing of glpD (191‐bp) gene | 5.6% 2/36 | Drancourt et al. ( | |
| Martigues ‐ France | 1720–1721 | 2.8% (1/36) | ||||
| Marseille ‐ France | 1722 | 3.6% (2/56) | ||||
| Montpellier ‐ France | 14th | Suicide PCR | Sequencing pla (148‐bp) gene | 86.9% (20/23) | Raoult et al. ( | |
| Venice – Italy | 14th−16th | Real time PCR and suicide PCR | Sequencing pla (98‐bp) gene and glpD (191‐bp) gene | 1.7% (3/173) | Tran, Signoli, et al. ( | |
| Aschheim ‐ Germany | 6th | Suicide PCR | Sequencing pla (148‐bp) gene | 33.3% (2/6) | Wiechmann and Grupe ( | |
| Bondy ‐ France | 11th−15th | Real time PCR and suicide nested PCR |
| 28.6% (4/14) | Tran, Forestier, et al. ( | |
|
Sens ‐ France Dreux ‐ France Montpellier ‐ France |
541–767 1346–1800 | Suicide PCR | Sequencing Multiple Spacer Typing | x/19 | Drancourt et al. ( | |
| Manching ‐ Pichl ‐ Germany | 1250–1500 | Multiplex PCR | Sequencing Pla gene | 4/20 individuals | Seifert et al. ( | |
| Brandenburg ‐ Germany | 1640 | Multiplex PCR | Sequencing Pla | 3/3 individuals | ||
| London ‐ England | 14th | Multiplex PCR | Sequencing Pla gene | 36.9% (17/46) | Schuenemann et al. ( | |
| Bergen op Zoom ‐ The Netherlands | 14th | Nested PCR | Sequencing pla (148‐bp) gene and caf1 (161‐bp) gene | 16.3% (7/43) | Haensch et al. ( | |
| Hereford ‐ England | 14th | 16.7% (2/12) | ||||
| Saint‐Laurent‐de‐la‐Cabrerisse ‐ France | 14th | 16.7% (1/6) | ||||
|
Lambesc ‐ France Draguignan ‐ France Berre l’Etang ‐ France Marseille ‐ France | 16th−18th | RDT |
|
4.4% (4/91) 4.4% (4/91) 4.4% (4/91) 4.4% (4/91) | Bianucci et al. ( | |
| Hereford ‐ England | 1335 ± 54 | 57.1% (4/7) | Haensch et al. ( | |||
| Poitiers ‐ France | 17th | X/7 | Bianucci et al. ( | |||
| La Chaize‐le‐Vicomte – France | 17−18th | X/7 | ||||
|
Bourges ‐ France Lariey ‐ France Sens ‐ France Bondy ‐ France Venice ‐ Italy |
17th 5th−6th 11th−15th 14th−16th | Real‐time PCR | 29.4% (10/34) | Malou et al. ( | ||
| ELISA | 8.8% (3/34) | |||||
| iPCR | 41.2% (14/34) | |||||
| Le Délos ‐ France | 18th | LC‐MS | Identifying four peptides at least | 16.7% (3/18) | Barbieri et al. ( | |
| Brandenburg ‐ Germany | 1618–1648 | PCR sequencing | SNP analysis | Seifert et al. ( | ||
| London‐England | 1348–1350 | NGS | 1 genome | Bos et al. ( | ||
| Marseille ‐ France | 1722 | NGS | 5 genomes | Bos et al. ( | ||
| Barcelona ‐ Spain | 1300–1420 | NGS | 1 genome | Spyrou et al. ( | ||
| Bolgar City ‐ Russia | 1362–1400 | NGS | 1 genome | |||
| Ellwangen ‐ Germany | 1485–1627 | NGS | 1 genome | |||
| Bavaria ‐ Germany | 426 –571 | NGS | 1 genome | Feldman et al. ( | ||
| Aschleim ‐ Germany | 541–543 | NGS | 2 genomes | Wagner et al. ( | ||
| Samara ‐ Russia | 3800 BP | NGS | 2 genomes | Spyrou et al. ( | ||
| Bateni ‐ Russia | 2909−2677 BC | NGS | 2 genomes | Rasmussen et al. ( | ||
| Sope ‐ Estonia | 2575–2349 BC | NGS | 1 genome | |||
| Bulavovo ‐ Russia | 2280−2047 BC | NGS | 1 genomes | |||
| Chociwel ‐ Poland | 2135–1923 BC | NGS | 1 genome | |||
| Kytmanovo ‐ Russia | 1746–1626 BC | NGS | 1 genome | |||
| Kapan ‐ Turkey | 1048–855 BC | NGS | 1 genome | |||
| Rasshevatskiy ‐ Russia | 4828–4622 BP | NGS | 1 genome | Andrades Valtueña et al. ( | ||
| Beli Manastir, Popova zemlja ‐ Croatia | 4833–4592 BP | NGS | 1 genome | |||
| Gyvakarai ‐ Lithuania | 4571–4422 BP | NGS | 1 genome | |||
| Kunila ‐ Estonia | 4524–4290 BP | NGS | 1 genome | |||
| Augsburg ‐ Germany | 4346–4098 BP | NGS | 1 genome | |||
| Augsburg ‐ Germany | 3957–3832 BP | NGS | 1 genome | |||
|
| Peyraoutes ‐ France | 4000 BC | Nested PCR | Sequencing of hbpE (283‐bp) gene and groEL (269‐bp) gene | 16.7% (1/6) | Drancourt et al. ( |
| Bondy ‐ France | 11−15th | Real time PCR | ITS (102‐bp) gene | 21.4% (3/14) | Tran, Forestier, et al. ( | |
| Venice ‐ Italia | 15th−16th | 2.9% (5/173) | Tran, Signoli, et al. ( | |||
| Douai ‐ France | 18th | 2.5% (1/40) | Nguyen‐Hieu et al. ( | |||
| Vilnius ‐ Lithuania | 1812 | Suicide nested PCR | Sequencing hbpE (282‐bp) gene and htrA (113‐bp) gene | 9.7% (7/72) | Raoult et al. ( | |
|
| Jerusalem ‐ Israel | 2025 ± 28 BP | Nested PCR |
RLEP gene, 18kDa Antigen, ribosomal protein S12 IS6110 | 1/11 (9%) | Matheson et al. ( |
|
| 3/11 (2.7%) | |||||
|
| Athen ‐ Greece | 430−426 BC | Suicide nested PCR | GosmC and clyA (322‐bp) gene and NarC (360‐bp) gene | 3/3 (100%) | Papagrigorakis et al. ( |
|
| Teposcolula‐Yucundaa ‐ Mexico | 1545–1550 CE | Metagenomic analysis | nd | Vågene et al. ( | |
|
| Oslo ‐ Norway | 15th |
Standard PCR Metagenomic analysis NGS |
Unknown gene (111‐bp) 1 genome | 2/18 (11.1%) | Guellil et al. ( |
|
| Kaliningrad ‐ Russia | 1812 | Standard PCR | Sequencing of non‐coding region of viral genome | 1/21 (4.8%) | Bédarida et al. ( |
|
| Vilnius ‐ Lithuania | 1812 | Suicide nested PCR | Sequencing dnaA (141‐bp) gene and dnaE (77‐bp) gene | 4/72 (5.6%) | Raoult et al. ( |
| Douai – France | 1710–1712 | Suicide real‐time nested PCR + suicide PCR | Sequencing ipp (152‐bp), gap(130‐bp) genes and rpmEtRNAfMet intergenic spacer (115‐bp) | 6/55 (10.9%) | Nguyen‐Hieu et al. ( | |
|
| Porto Ercole – Italy | 1610 | Non specific metagenomic + real time PCR + metaproteomic | nd | Drancourt et al. ( | |
| Pathogen detection in ancient dental pulp of cat | ||||||
|
| Paris ‐ France | 13th | Nested PCR | Sequencing groEL (269‐bp) gene and Pap31 (164‐bp) | 1/4 cats | La et al. ( |
| Montbéliard ‐ France | 14th | 1 cat | ||||
| Compiègne ‐ France | 16th | 1/7 cats | ||||